Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17131 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Min-Ok Ryu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Science and Research Institute for Veterinary Scien…. Hauptthemen laut MEDLINE: Thrombopoietin, Receptors, Fc, Recombinant Fusion Proteins, Dog Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Romiplostim, a thrombopoietin analog, is commonly used to treat immune-mediated thrombocytopenia (ITP) in humans, but its use in dogs remains limited.
Objectives
Evaluate the effects and adverse events of romiplostim administration in dogs with thrombocytopenia caused by various underlying diseases. Animals Forty-two client-owned dogs with naturally occurring thrombocytopenia at 2 referral animal hospitals.
Methods
Retrospective, multi-institutional analysis to evaluate the outcomes of romiplostim treatment in dogs.
Results
Among the dogs treated with romiplostim, 27 experienced an increase in platelet count and 26 maintained a platelet count within the reference range. Platelet count improvement was observed in various conditions: primary ITP (90%, n = 18/20), pancytopenia of unknown etiology (42.9%, n = 3/7), chemotherapy-induced thrombocytopenia (50%, n = 3/6), babesiosis (100%, n = 1/1), radiotherapy-induced thrombocytopenia (0%, n = 0/1), and disseminated intravascular coagulopathy (33.3%, n = 2/6). The median time for platelet recovery (>50 000/μL) after romiplostim administration was 4 days, and the median time for platelet count normalization was 7 days. Median hospitalization time for the improvement group (I) was 5 days. The survival-to-discharge rates were 85%, 40%, and 28.6% for dogs with primary ITP, secondary thrombocytopenia, and thrombocytopenia of unknown etiology, respectively. Conclusions and Clinical Importance Romiplostim is a well-tolerated and promising treatment for primary ITP in dogs, suggesting its potential as a valuable therapeutic option for dogs with thrombocytopenia caused by various underlying conditions. These findings emphasize the need for further research to optimize romiplostim dosing and understand its role in treating secondary thrombocytopenia and pancytopenia of unknown etiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Science and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
- Haemaru Companion Animal Medical Foundation, Seongnam, Republic of Korea.
- Department of Veterinary Emergency and Critical Care Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University, Chuncheon-si, Republic of Korea.
- Department of Veterinary Internal Medicine, College of Veterinary Medicine & Institute for Veterinary Biomedical Science, Kyungpook National University, Daehakro 80, Daegu, Republic of Korea.
ORCID-Profile: Min-Ok Ryu, Jin-Kyung Kim, Ju-Hyun An, Kyoung-Won Seo, Ye-In Oh, Hwa-Young Youn
Zitieren
APA
Ryu, M. O., Kim, J. K., An, J. H., Seo, K. W., Oh, Y. I., & Youn, H. Y. (2024). Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17131
Vancouver
Ryu MO, Kim JK, An JH, Seo KW, Oh YI, Youn HY. Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17131
BibTeX
@article{Ryu2024,
author = {Ryu, Min-Ok and Kim, Jin-Kyung and An, Ju-Hyun and Seo, Kyoung-Won and Oh, Ye-In and Youn, Hwa-Young},
title = {Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17131}
}
EUVIMED